摘要
目的：对曲美他嗪与美托洛尔联合治疗冠心病心力衰竭的临床效果进行分析研究。方法选取于2014年2月～2015年2月期间在我院接受治疗的46例冠心病心力衰竭患者并将患者随机分为两组，对照组患者给予常规内科治疗，治疗组患者在常规内科治疗的基础上给予曲美他嗪与美托洛尔联合治疗，对两组患者的临床疗效进行比较。结果治疗组患者的治疗总有效率高于对照组，并且LVEF、LVEDD和LVESD等心血管功能指标均优于对照组，差异显著，治疗有统计学意义（P＜0.05）。结论曲美他嗪与美托洛尔联合治疗冠心病心力衰竭的临床效果显著，能改善患者的心功能等级以及心血管功能。
Objective Clinical effect of Trimetazidine combined with Metoprolol in treatment of coronary heart disease complicated with heart failure is to be investigated.MethodsChoose 46 patients of coronary heart disease complicated with heart failure that are treated in hospital from February 2014 to February 2015 and separate them into two groups at random; patients in control group are given conventional medical treatment and patients in study group are given additional Trimetazidine combined with Metoprolol treatment; and then compare clinical treatment effects between two groups. ResultsPatients’ treatment improvement rate in study group is much higher than that in control group; besides, patients’ cardiovascular indicators of LVEF, LVEDD and LVESD in study group are much more favorable than counterparts in control group; there is a differential between two groups and such a differential has statistic value （P〈0.05）. ConclusionTrimetazidine combined with Metoprolol is of efficacy in treatment of coronary heart disease complicated with heart failure; it is conducive to improving patients’ heart function as well as cardiovascular function; thus, such a medication treatment is quite worthwhile to be promoted and applied clinically.
出处
《中国继续医学教育》
2015年第12期135-136,共2页
China Continuing Medical Education
关键词
曲美他嗪
美托洛尔
冠心病心力衰竭
Trimetazidine
Metoprolol
Coronary heart disease complicated with heart failure
